135 related articles for article (PubMed ID: 24178909)
1. Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.
Galoian KA; Guettouche T; Issac B; Qureshi A; Temple HT
Tumour Biol; 2014 Mar; 35(3):2335-41. PubMed ID: 24178909
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1.
Galoian K; Qureshi A; D'Ippolito G; Schiller PC; Molinari M; Johnstone AL; Brothers SP; Paz AC; Temple HT
Int J Oncol; 2015 Aug; 47(2):465-72. PubMed ID: 26094604
[TBL] [Abstract][Full Text] [Related]
3. Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma.
Galoian K; Abrahamyan S; Chailyan G; Qureshi A; Patel P; Metser G; Moran A; Sahakyan I; Tumasyan N; Lee A; Davtyan T; Chailyan S; Galoyan A
Int J Oncol; 2018 Jan; 52(1):139-154. PubMed ID: 29138803
[TBL] [Abstract][Full Text] [Related]
4. PRP‑1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β‑catenin pathway in human chondrosarcoma JJ012 cells.
Hoyt AK; Moran A; Granger C; Sedani A; Saigh S; Brown J; Galoian KA
Oncol Rep; 2019 Jul; 42(1):103-114. PubMed ID: 31180539
[TBL] [Abstract][Full Text] [Related]
5. Cytostatic effect of the hypothalamic cytokine PRP-1 is mediated by mTOR and cMyc inhibition in high grade chondrosarcoma.
Galoian K; Temple TH; Galoyan A
Neurochem Res; 2011 May; 36(5):812-8. PubMed ID: 21243426
[TBL] [Abstract][Full Text] [Related]
6. Proline‑rich polypeptide‑1 decreases cancer stem cell population by targeting BAFF chromatin‑remodeling complexes in human chondrosarcoma JJ012 cells.
Moran A; Hoyt A; Sedani A; Granger C; Saigh S; Blonska M; Zhao-Ju L; Conway SA; Pretell J; Brown J; Galoian K
Oncol Rep; 2020 Jul; 44(1):393-403. PubMed ID: 32627042
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor promotes VEGF-C-dependent lymphangiogenesis by suppressing miR-624-3p in human chondrosarcoma cells.
Lin CY; Wang SW; Chen YL; Chou WY; Lin TY; Chen WC; Yang CY; Liu SC; Hsieh CC; Fong YC; Wang PC; Tang CH
Cell Death Dis; 2017 Aug; 8(8):e2964. PubMed ID: 28771226
[TBL] [Abstract][Full Text] [Related]
8. mTORC1 inhibition and ECM-cell adhesion-independent drug resistance via PI3K-AKT and PI3K-RAS-MAPK feedback loops.
Galoian K; Temple HT; Galoyan A
Tumour Biol; 2012 Jun; 33(3):885-90. PubMed ID: 22246604
[TBL] [Abstract][Full Text] [Related]
9. Myc-oncogene inactivating effect by proline rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.
Galoian K; Scully S; Galoyan A
Neurochem Res; 2009 Feb; 34(2):379-85. PubMed ID: 18612811
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide‑1.
Granger CJ; Hoyt AK; Moran A; Becker B; Sedani A; Saigh S; Conway SA; Brown J; Galoian K
Mol Med Rep; 2020 Nov; 22(5):3747-3758. PubMed ID: 32901865
[TBL] [Abstract][Full Text] [Related]
11. What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
Palmini G; Marini F; Brandi ML
Molecules; 2017 Mar; 22(3):. PubMed ID: 28272374
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression.
Tsai CH; Yang DY; Lin CY; Chen TM; Tang CH; Huang YL
Mol Oncol; 2017 Oct; 11(10):1380-1398. PubMed ID: 28672103
[TBL] [Abstract][Full Text] [Related]
13. miRNA-497 Negatively Regulates the Growth and Motility of Chondrosarcoma Cells by Targeting Cdc25A.
Lu Y; Li F; Xu T; Sun J
Oncol Res; 2016; 23(4):155-63. PubMed ID: 27053344
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Src by microRNA-23b increases the cisplatin sensitivity of chondrosarcoma cells.
Huang K; Chen J; Yang MS; Tang YJ; Pan F
Cancer Biomark; 2017; 18(3):231-239. PubMed ID: 28085008
[TBL] [Abstract][Full Text] [Related]
15. Analysis of microRNAs expressions in chondrosarcoma.
Yoshitaka T; Kawai A; Miyaki S; Numoto K; Kikuta K; Ozaki T; Lotz M; Asahara H
J Orthop Res; 2013 Dec; 31(12):1992-8. PubMed ID: 23940002
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR.
Zhu Z; Wang CP; Zhang YF; Nie L
Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519
[TBL] [Abstract][Full Text] [Related]
17. Compensatory Increase of Transglutaminase 2 Is Responsible for Resistance to mTOR Inhibitor Treatment.
Cao J; Huang W
PLoS One; 2016; 11(2):e0149388. PubMed ID: 26872016
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
[TBL] [Abstract][Full Text] [Related]
19. Antitumorigenic effect of brain proline rich polypeptide-1 in human chondrosarcoma.
Galoian K; Scully S; McNamara G; Flynn P; Galoyan A
Neurochem Res; 2009 Dec; 34(12):2117-21. PubMed ID: 19484491
[TBL] [Abstract][Full Text] [Related]
20. The expression of miR-181a-5p and miR-371b-5p in chondrosarcoma.
Mutlu S; Mutlu H; Kirkbes S; Eroglu S; Kabukcuoglu YS; Kabukcuoglu F; Duymus TM; ISık M; Ulasli M
Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2384-8. PubMed ID: 26214773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
